139 parallel-processing-bioinformatics positions at University of Manchester in United Kingdom
Sort by
Refine Your Search
-
Listed
-
Category
-
Program
-
Field
-
with academic, administrative and external customers, to facilitate the smooth running of day-to-day activities, through the delivery of established processes. The post holder will act as a first point
-
demonstrable and successful track record of independent and collaborative problem solving and who can foster a culture of team work, whilst being able to support and develop continuous improvement to process and
-
will rely on mixed methods to identify and investigate how different forms of social and built infrastructure contribute to the decision-making processes and capacities of just transformation actors, and
-
projects funded by a grant from the Engineering and Physical Sciences Research Council (EPSRC) we have started to establish processes and systems for the long-term storage of, and access to, materials
-
Institute, the UKs center for advanced materials science, giving access to leading materials science and engineering techniques. You will focus on powder processing, fabrication, characterisation and
-
cultural heritage is mirrored by the achievements of some of the University’s most celebrated names. The computer revolution started here in June 1948 when a machine built by Tom Kilburn and Sir Freddie
-
computer. Now, we’re writing the next chapter with Unit M, our new innovation unit designed to unlock the full innovation impact of the University for our city, our region, and the world. Unit M exists
-
Business. Nationality restrictions This funding is available to students from: Other eligibility criteria As determined by CONACyT. Application procedure Please see CONACyT website for details. Application
-
with your application now you acknowledge that you are aware that such screening will take place, and agree to take part in the process. What you will get in return: Fantastic market leading Pension
-
processes that can be targeted to develop new treatments against brain tumours that form in individuals with the rare disease NF2 schwannomatosis. The successful candidate will join the lab of Prof. Kevin